Article Information
History
- October 6, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Sameer S. Bajikar1,2,
- Ashley G. Anderson1,2,
- Jian Zhou1,2,
- Mark A. Durham2,3,4,
- Alexander J. Trostle2,5,
- Ying-Wooi Wan1,2,
- Zhandong Liu2,5 and
- Huda Y. Zoghbi1,2,3,5,6,*
- 1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA
- 2Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, TX, 77030, USA
- 3Program in Developmental Biology, Baylor College of Medicine, Houston, TX, 77030, USA
- 4Medical Scientist Training Program, Baylor College of Medicine, Houston, TX, 77030, USA
- 5Department of Pediatrics, Baylor College of Medicine, Houston, TX, 77030, USA
- 6Howard Hughes Medical Institute, Baylor College of Medicine, Houston, TX, 77030, USA
- ↵*Corresponding author: Huda Y. Zoghbi; address: Jan and Dan Duncan Neurological Research Institute, 1250 Moursund Street, Suite 1350, Houston, TX, 77030; phone: 713-798-6558; email: hzoghbi{at}bcm.edu
Posted October 06, 2022.
MeCP2 regulates Gdf11, a dosage-sensitive gene critical for neurological function
